News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
14,346 Results
Type
Article (915)
Company Profile (6)
Press Release (13424)
Section
Business (3776)
Career Advice (15)
Deals (560)
Drug Delivery (1)
Drug Development (1912)
FDA (210)
Job Trends (205)
News (6493)
Policy (502)
Tag
2027 Pharm Country Standard (1)
Academia (106)
Adcomms (1)
Allergies (1)
Alliances (1654)
ALS (5)
Alzheimer's disease (38)
Antibody-drug conjugate (ADC) (4)
Approvals (214)
Artificial intelligence (50)
Automation (2)
Bankruptcy (1)
Best Places to Work (150)
Biotechnology (5)
Bladder cancer (2)
Breast cancer (4)
Cancer (69)
Cardiovascular disease (12)
Career advice (13)
CAR-T (2)
Cell therapy (8)
Clinical research (1562)
Collaboration (65)
Compensation (29)
COVID-19 (54)
CRISPR (3)
C-suite (11)
Cystic fibrosis (4)
Data (139)
Depression (3)
Diabetes (11)
Diagnostics (76)
Digital health (2)
Drug discovery (19)
Drug pricing (3)
Earnings (1024)
Editorial (1)
Events (1533)
Executive appointments (12)
FDA (258)
Funding (36)
Gene editing (4)
Generative AI (8)
Gene therapy (12)
GLP-1 (30)
Government (38)
Guidances (12)
Healthcare (258)
HIV (1)
Huntington's disease (1)
Immunology and inflammation (1)
Immuno-oncology (3)
Indications (3)
Infectious disease (57)
Inflammatory bowel disease (5)
Influenza (1)
Intellectual property (8)
Interviews (4)
IPO (164)
IRA (1)
Job creations (39)
Job search strategy (10)
JPM (2)
Layoffs (2)
Legal (143)
Liver cancer (2)
Lung cancer (4)
Lymphoma (9)
Machine learning (6)
Manufacturing (50)
MASH (4)
Medical device (140)
Medtech (142)
Mergers & acquisitions (424)
Metabolic disorders (23)
Multiple sclerosis (1)
Neurodegenerative disease (5)
Neuropsychiatric disorders (1)
Neuroscience (63)
NextGen: Class of 2026 (85)
Non-profit (33)
Now hiring (2)
Obesity (8)
Opinion (4)
Ovarian cancer (3)
Pain (1)
Pancreatic cancer (2)
Parkinson's disease (5)
Partnered (5)
Patents (14)
Patient recruitment (15)
People (1006)
Pharmaceutical (1)
Phase 1 (523)
Phase 2 (740)
Phase 3 (453)
Pipeline (128)
Policy (2)
Postmarket research (36)
Preclinical (330)
Press Release (64)
Prostate cancer (2)
Psychedelics (1)
Radiopharmaceuticals (4)
Rare diseases (18)
Real estate (150)
Regulatory (372)
Research institute (70)
Resumes & cover letters (3)
RNA editing (1)
RSV (1)
Schizophrenia (5)
Series A (5)
Series B (5)
Sickle cell disease (1)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (90)
Supply chain (4)
Tariffs (2)
Vaccines (26)
Venture capital (1)
Weight loss (5)
Women's health (1)
Date
Today (1)
Last 7 days (21)
Last 30 days (61)
Last 365 days (603)
2026 (73)
2025 (609)
2024 (827)
2023 (931)
2022 (1422)
2021 (1297)
2020 (1184)
2019 (781)
2018 (537)
2017 (674)
2016 (705)
2015 (761)
2014 (527)
2013 (509)
2012 (546)
2011 (581)
2010 (452)
Location
Africa (14)
Alabama (1)
Alaska (1)
Arizona (2)
Asia (957)
Australia (116)
California (363)
Canada (77)
China (25)
Colorado (1)
Delaware (7)
Europe (2304)
Florida (19)
Illinois (13)
India (4)
Indiana (6)
Iowa (2)
Japan (8)
Kentucky (1)
Louisiana (1)
Maine (1)
Maryland (11)
Massachusetts (127)
Michigan (4)
Minnesota (7)
Missouri (2)
Montana (1)
Nebraska (1)
New Jersey (119)
New Mexico (1)
New York (56)
North Carolina (17)
North Dakota (3)
Northern California (218)
Ohio (4)
Oklahoma (2)
Oregon (1)
Pennsylvania (35)
South America (10)
Southern California (102)
Texas (22)
United States (826)
Utah (9)
Virginia (2)
Washington State (4)
Wisconsin (2)
14,346 Results for "depuy synthes".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
DePuy Synthes Receives 510(k) FDA Clearance of the VELYS™ Robotic-Assisted Solution for Use in Unicompartmental Knee Arthroplasty Procedures
Johnson & Johnson MedTech* announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson**, has received 510 FDA clearance for the clinical application of the VELYS™ Robotic-Assisted Solution in Unicompartmental Knee Arthroplasty.
June 7, 2024
·
9 min read
Press Releases
DePuy Synthes Launches its First Active Spine Robotics and Navigation Platform
August 2, 2024
·
6 min read
FDA
DePuy Synthes Receives FDA Clearance for TELIGEN™ System
Today, Johnson & Johnson MedTech* announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson, has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its TELIGEN™ System.
October 20, 2022
·
10 min read
Biotech Beach
Innovative Platform for Tracking High-Value Medical DevicesTruepic to Work with “DePuy Synthes Canada*” to Increase Efficiency and Reduce Risk
Truepic, the leader in digital image provenance and authenticity, will work with DePuy Synthes Canada* by integrating the Truepic Vision platform seamlessly into their operations process.
August 1, 2022
·
1 min read
BioMidwest
DePuy Synthes Launches the UNIUM™ System as a Next Generation Power Tools System for Trauma and Small Bone Procedures
DePuy Synthes, The Orthopaedics Company of Johnson & Johnson*, has launched the UNIUM™ System as the newest addition to its Power Tools portfolio.
November 22, 2021
·
6 min read
BioMidwest
DePuy Synthes Further Reimagines Knee Restoration with the Addition of Two New Innovations to the ATTUNE™ Knee Portfolio
Johnson & Johnson MedTech* announced that DePuy Synthes,** The Orthopaedics Company of Johnson & Johnson, is adding two new innovations to its kinematically advanced and proven ATTUNE™ Knee portfolio: the ATTUNE™ Cementless Fixed Bearing Knee with AFFIXIUM™ 3DP Technology and the ATTUNE™ Medial Stabilized Knee System.
March 16, 2022
·
11 min read
Genetown
DePuy Synthes to Showcase Innovation Momentum at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting
The Johnson & Johnson Medical Devices Companies* announced that DePuy Synthes,** The Orthopaedics Company of Johnson & Johnson, will feature new products and technology solutions shaping new standards of care for modern day orthopaedics during the American Academy of Orthopaedic Surgeons (AAOS) annual meeting
August 25, 2021
·
12 min read
Genetown
DePuy Synthes Introduces the INHANCE™ Shoulder System, a First-to-Market, Fully Integrated Shoulder Arthroplasty System
Today, The Johnson & Johnson Medical Devices Companies* announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson,** introduces the INHANCE™ Shoulder System, a first-to-market, fully integrated shoulder arthroplasty system.
August 18, 2021
·
7 min read
Press Releases
Johnson & Johnson Announces Intent to Separate Its Orthopaedics Business
October 15, 2025
·
9 min read
DePuy Synthes Receives 510(k) FDA Clearance for VELYS™ Robotic-Assisted Solution Designed for Use with the ATTUNE® Total Knee System
Today, The Johnson & Johnson Medical Devices Companies* announced that DePuy Synthes** has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VELYS™ Robotic-Assisted Solution designed for use with the ATTUNE® Total Knee System and its cleared indications for use.
January 19, 2021
·
8 min read
1 of 1,435
Next
